| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000269696.1 |
AKT inhibitor VIII |
Breast invasive carcinoma |
0.018212511 |
Resistant |
| ENSG00000269696.1 |
AKT inhibitor VIII |
Colon adenocarcinoma |
0.002617257 |
Resistant |
| ENSG00000269696.1 |
AKT inhibitor VIII |
Bladder urothelial carcinoma |
0.025452514 |
Sensitive |
